Fundraising Fox

Vavotar Life Sciences

Cumming, US · Founded 2015 · Delaware LLC

Healthtech

Founders & leadership

MAMartin A. Bell
Martin A. BellinExecutive
CF
Charles FarraharExecutive
SG
Steve GorlinNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$156M disclosed across 6 rounds · 2015–2018

▶$10MraisedJan 2019 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew DanielsenDirector
  • James A. RogersDirector
  • Charles FarraharExecutive Officer
  • Steve GorlinExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
Minimum investment
$6.3K
Sales commissions
$156K
Placement agents
Finsoft Consultants, Inc., Ashley Johnson, Virginia Dadey
First sale
Nov 2018
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80.8MraisedSep 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick Soon-ShiongDirector
  • Charles FarraharExecutive Officer
  • Martin A. BellExecutive Officer
  • Jesse W. CrowneExecutive Officer
  • Steve GorlinExecutive Officer, Director
Offering amount
$80.8M
Amount sold
$80.8M
First sale
Aug 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedSep 2016 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles FarraharExecutive Officer
  • Jesse W. CrowneExecutive Officer
  • Steve GorlinExecutive Officer, Director
  • Martin A. BellExecutive Officer
  • Patrick Soon-ShiongDirector
Offering amount
$21M
Amount sold
$21M
First sale
Aug 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedSep 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick Soon-ShiongDirector
  • Steve GorlinExecutive Officer, Director
  • Charles FarraharExecutive Officer
  • Jesse W. CrowneExecutive Officer
  • Martin A. BellExecutive Officer
Offering amount
$40.6M
Amount sold
$40.6M
First sale
Aug 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedMay 2016 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles FarraharExecutive Officer
  • Jesse W. CrowneExecutive Officer
  • Martin A. BellExecutive Officer
  • Steve GorlinExecutive Officer, Director
Offering amount
$4.5M
Amount sold
$3.5M
First sale
Mar 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$675raisedJan 2016 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin A. BellExecutive Officer
  • Charles FarraharExecutive Officer
  • Steve GorlinExecutive Officer, Director
Offering amount
$675
Amount sold
$675
First sale
Sep 2015
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Mayo’s Precision Chemotherapy Delivery Platform Attracts Investor Attention | Twin Cities Businesstcbmag.com · Jul 2016

Frequently asked questions

How much funding has Vavotar Life Sciences raised?
Vavotar Life Sciences has disclosed $156M raised across 6 rounds.
Where is Vavotar Life Sciences headquartered?
Vavotar Life Sciences is headquartered in Cumming, US.